AnthonyJamesJapourMD

Infectious Disease • Miami, FL

Physician

Join to view full profile

Dr. Japour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Japour's full profile

Already have an account?

Office
650 NE 32nd St
#2301
Miami, FL 33137

Education & Training

Mount Auburn HospitalResidency, Internal Medicine, 1986 - 1989
Northwestern University The Feinberg School of MedicineClass of 1986

Certifications & Licensure

FL State Medical License 2003 - 2026
MA State Medical License 1987 - 2007
IL State Medical License 1997 - 2002
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Completed
Phase 1

Publications & Presentations

PubMed

26 citations
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update.
Piotr Witkowski, Louis H. Philipson, Dixon B. Kaufman, Lloyd E. Ratner, Marwan S Abouljoud
American Journal of Transplantation. 2021-04-01
9 citations
Regulatory updates are needed to prevent commercialization of islet transplantation in the US.
Piotr Witkowski, Rolf N. Barth, Anthony J. Japour, Gail H. Javitt, Jordan Pyda
American Journal of Transplantation. 2021-03-08
42 citations
Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.
Paul Coplan, Alexander Nikas, Anthony J. Japour, Karen Cormier, Hilal Maradit-Kremers
AIDS Research and Human Retroviruses. 2003-06-01

Press Mentions

Diabetes Research Institute Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024June 21st, 2024
Preclinical Study Demonstrates Long-Term Success of Allogeneic Islet Implantation for DiabetesMay 17th, 2022
iTolerance, Inc. Announces Formation of Scientific Advisory Board with Appointment of International Leaders in Immune Tolerance DiscoveriesSeptember 13th, 2021

Grant Support

ZDV Resistance In Maternal/Infant HIV-1 TransmissionNational Institute Of Allergy And Infectious Diseases1995–1997
Drug Resistant HIV-1 Rt--Molecular Structure &FunctionNational Institute Of Allergy And Infectious Diseases1992–1995